Cell Signaling Technology

Phospho-SQSTM1/p62 (Thr269/Ser272) Antibody

#13121 · $366

60
Evidence Score · Well-Established
Used by 74 independent labs across 91 papers. How we score this →
90
Citing papers
3.2k
Combined citations
Supplier page Find this product

Research areas

Fibroblast Growth Factor Research14Autophagy in Disease and Therapy10Ubiquitin and proteasome pathways6MicroRNA in disease regulation5Epigenetics and DNA Methylation5Cancer, Hypoxia, and Metabolism5Cancer, Lipids, and Metabolism4Bladder and Urothelial Cancer Treatments4

Papers citing this product

1
The adult human testis transcriptional cell atlas
Cell Research·2018·769 cit.·DOI
2
Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas
Blood·2007·296 cit.·DOI
3
Facile syntheses of conjugated polymers for photothermal tumour therapy
Nature Communications·2019·220 cit.·DOI
4
Rapidly Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in NSCLC Cell Lines through De-Repression of FGFR2 and FGFR3 Expression
PLoS ONE·2010·145 cit.·DOI
5
Programmed cell death in the embryonic central nervous system of <i>Drosophila melanogaster</i>
Development·2006·119 cit.·DOI
6
Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
Cell Death and Disease·2017·118 cit.·DOI
7
Structural basis for FGF hormone signalling
Nature·2023·115 cit.·DOI
8
Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis
Cell Death and Disease·2018·72 cit.·DOI
9
NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway
Nature Communications·2015·70 cit.·DOI
10
Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions
Oncogenesis·2018·65 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.